Term
Types of VTE(venous thromboembolism) |
|
Definition
PE(pulmonary Embolism)-deadly in mins DVT(deep vein thrombosis)-rarely fatal
[result from clot formation in vein circ] |
|
|
Term
|
Definition
-orthopedic procedures -multiple traumas -stroke pt,MI,Spinal cord injury -Estrogen oral contraceptives -pregnancy |
|
|
Term
most common genetic disorder of hypercoagulability |
|
Definition
Activated protein C (aPC) resistance [mutation is known as factor V Leiden.mutation on factor V that renders it resistant to degradation by aPC] |
|
|
Term
PE typically presents with |
|
Definition
chest pain SOB tachypnea tachycardia |
|
|
Term
long-term complication of DVT presents with |
|
Definition
lower extremity swelling, pain, tenderness, skin discoloration, and, in the most severe cases, ulceration |
|
|
Term
|
Definition
A normal full leg ultrasound or highly sensitive D-dimer |
|
|
Term
|
Definition
Formation of plaque that occludes blood flow |
|
|
Term
|
Definition
-Binds factor III via pentasacharide sequence -binds and inhibits thrombin(factr 2a) -anti Xa:anti 2a inhibition in 1:1 ratio FROM PORCINE |
|
|
Term
Heparin not used therapeutically bc---- |
|
Definition
Poor absorption (1.5 hr 1/2 life) |
|
|
Term
aPTT range determined by anti-Xa conc between |
|
Definition
0.3-0.7
can change if diff reagent used |
|
|
Term
|
Definition
-same as heparin but Anti-Xa:anti 2a inhibiton ratio 4:1 (Lovenox,Fragmin) |
|
|
Term
Lovenox (enoxaparin) Requires ____ LMWH |
|
Definition
renal adj (prolonged) FROM PORCINE |
|
|
Term
|
Definition
Requires renal adj renal dysf 3.7-7.7 hrs Therapeutic:0.5-1.5 D Prophylaxis:0.2-0.6 FROM PORCINE |
|
|
Term
Arixtra(fondaparinux) SYNTHETIC |
|
Definition
Chain length too short to inhibit 2a.only inhibits only Xa (renal adj) SYNTHETIC |
|
|
Term
Peak levels of LMWH shud be acheived at about---- |
|
Definition
|
|
Term
Angiomax (Bivalrudin) Metabolized by IV |
|
Definition
plasma proteases (immediate onset) monitored by ACT if undergoing pci aPTT 1.5-2.5x initial pt baseline |
|
|
Term
Acove (argatroban) Metabolised by IV |
|
Definition
liver Hepatic adj aPTT 1.5-3 initial pt baseline monitored by ACT if undergoing pci |
|
|
Term
Pradaxa (dabigatran etexilate) PO |
|
Definition
has bad absorption (dont open capsule_>inc absorp 75%!) Hepatic glucuronidation |
|
|
Term
DTI (direct thrmbin inhibtors) can cause FALSE..... |
|
Definition
elevation in INR especially ARGATROBAN |
|
|
Term
Do not use this DTI in hepatic dysfunction |
|
Definition
|
|
Term
Warfarin (COUMADIN) MOA Wisconsin alumni research foundation |
|
Definition
-Racemic mixture inhibits production of vitamin K by inhibiting vitk epoxide reductase -tyopically start w/ another anticoag to allow for clotting factors to go away due to warf acting only on new factors -1948 approved as rat poison(FDA 1954) |
|
|
Term
|
Definition
HEPATIC (peak effect 5-7 days) |
|
|
Term
|
Definition
-Antibiotics -Aspirin (compete for binding sites) -amiodarone -Nafcillin, rifampin,carbamazepine (dec effect of Warf) |
|
|
Term
WARFARIN Drug disease interxn |
|
Definition
INC EFFECT Fever,acute ill -hyperthyroid - AHF Hypoalbuminemia DEC EFFECT=smoking,alcoholism |
|
|
Term
|
Definition
XARELTO (rivaroxaban) ELIQUIS (apixaban) SAVAYSA (edoxaban) BEVYXXA (betrixaban) |
|
|
Term
|
Definition
reversibly inhibits free & clotbound factor Xa (PT may or may not be monitored) |
|
|
Term
Xarelto give with food for doses |
|
Definition
Greater than or equal to 15mg [hepatic metab] |
|
|
Term
|
Definition
(INC EFFCT) -AZOLES -Non-DHP CCBs -Atorvastatin -Digoxin -amiodarone |
|
|
Term
|
Definition
Bleeding(GI,Intraranial[warf>DOACs],bruising] -GI Sxs(dabigatran) -HITT(hep induced thrombocytopeniaw/ thrombosis) |
|
|
Term
Reversal Agents [Test to confirm] Heparin= |
|
Definition
|
|
Term
Reversal Agents [Test to confirm] Warfarin= |
|
Definition
Vitamin K, four-factor PCC(2,7,9,10), FFP PT/INR |
|
|
Term
Reversal Agents [Test to confirm] DTIs=
Direct Thrombin Inhibitors |
|
Definition
Idarucizamab(Praxbind®):dabigatran Note: reversal typically not necessary for IV products due to short half-life [Thrombin Time,aPTT] |
|
|
Term
Reversal Agents [Test to confirm] FActor Xa Inhibitors= |
|
Definition
PCC, andexanetalfa (pending FDA-approval) [PT,chromogenic factor Xa] |
|
|
Term
Glycoprotein IIb/IIIaInhibitors MOA |
|
Definition
MOA: blocks the platelet glycoprotein IIb/IIIareceptor, the binding site for fibrinogen, von Willebrandfactor, and other ligands; reversibly blocks platelet aggregation and prevents thrombosis |
|
|
Term
Glycoprotein IIb/IIIaInhibitors USE |
|
Definition
|
|
Term
Integrilin (eptifibatide) |
|
Definition
|
|
Term
|
Definition
Irreversibly inhibits cyclooxygenase(COX)-1 by acetylation; decrease in thromboxane production (decreased platelet aggregation) |
|
|
Term
|
Definition
NSAIDs compete for COX and by the time they reversibly leave not enough Aspirin is LEFT to bind (Major intrxn) |
|
|
Term
|
Definition
MOA: block the P2Y12 component of the ADP receptor on platelets which prevents conformational change (activation) of the GP-IIB/IIIA complex, reducing platelet activation/ aggregation |
|
|
Term
Fibrinolytics / Thrombolytics MOA |
|
Definition
Binds to thrombin in a clot and converts plasminogen to plasmin –Plasmin responsible for clot lysis |
|
|
Term
Fibrinolytics / Thrombolytics USE |
|
Definition
–STEMI –Acute ischemic stroke –Acute pulmonary embolism |
|
|
Term
|
Definition
Lovenox(ENoxaparin)
Fragmin(Dalteparin)
Arixtra(fondaparinux) |
|
|
Term
|
Definition
aPTT,ANti Xa, ACT(during hi dosing) |
|
|
Term
|
Definition
non renal at therapeutic dosing |
|
|
Term
|
Definition
|
|
Term
|
Definition
HIT Heparin induced thrombocytopenia |
|
|
Term
DTIs (use aPTT to monitor) |
|
Definition
ANgiomax(Bivalrudin) Acova(argatroban) Pradaxa(Dabigatran) |
|
|
Term
DTI that cant be used with hep dysfunc |
|
Definition
|
|
Term
DTI cant be used in renal dysf |
|
Definition
|
|
Term
Xa factor inhibitors and Pradaxa require |
|
Definition
|
|
Term
|
Definition
Dronedarone Azoles Rifampin,st jon wrt HIV protease(xarelto) |
|
|
Term
HITT is not associated with |
|
Definition
|
|
Term
Reversal is not needded in IV.... |
|
Definition
DTI direct thrombin inhibitors due to short half life |
|
|
Term
|
Definition
Integrilin(eptifibatide) Reopro(Abciximab) Aggrastat (tirofiban) |
|
|
Term
only nonreversible G IIb/IIIa inhibitor |
|
Definition
|
|
Term
G IIb/IIIa inhibitors can cause |
|
Definition
Thrombocytopenia and bleeding |
|
|
Term
|
Definition
Plavix (Clopidogrel) Effient (Prasugrel) Brilinta (Ticagrelor) |
|
|
Term
Ticagrelors inhibition is |
|
Definition
|
|
Term
Max aspirin dose with Ticagrelor |
|
Definition
|
|
Term
|
Definition
Activase (alteplase) Retevase (reteplase) TNKase (tenecteplase) |
|
|
Term
|
Definition
plasminogen to plasmin
use STEMI acuteischem stroke acute pulm embolism |
|
|